After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring
Thanks: MarketWatch – United States | 2026-09-25 09:11
According to a report by MarketWatch… Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal complete report is on link below. Source: https://www.marketwatch.com/story/after-capital-markets-day-flop-novo-strikes-licensing-deal-that-sends-a-swedish-companys-stock-soaring-f3c99cbe?mod=mw_rss_topstories